A study conducted in the North-East region of Colombia found 11.94% of patients with a high BMI being treated for breast cancer at a regional center experienced heart damage, or cardiotoxicity, during chemotherapy.
University of Pittsburgh researchers have demonstrated how Merkel cell polyomavirus, which causes Merkel cell carcinoma, initiates DNA replication in host cells.
A study by Main Line Health researchers indicates that simultaneously conducting a liquid biopsy and standard tissue biopsy increases the chances of detecting such mutations and is practical for wide usage by hospitals.
In patients with wild-type TP53 advanced or recurrent endometrial cancer, the addition of maintenance therapy with Xpovio (selinexor) following systemic therapy may prolong progression-free survival, according to research that will be presented during the July 2023 session of the American Society of Clinical Oncology Plenary Series.
Phase III trials ATLAS and ENVISION studying UGN-102 (mitomycin) for intravesical solution in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) met their primary endpoints.
Increased skin cancer screening in individuals with skin of color is not sufficient to address racial disparities in melanoma survival rates, according to a new JAMA Dermatology study by UPMC and University of Pittsburgh researchers.
A team headed by the Medical University of Vienna examined cancer prevalence and screening/prevention awareness among people who are experiencing homelessness in four European countries. The team proposed approaches for the development of a prevention program using the results. The study was published in eClinicalMedicine.
Researchers from the Keck School of Medicine of USC discovered that when cells are under stress, a key protein can travel to the nucleus and reprogram cells to migrate and become more invasive.
A novel blood testing technology being developed by researchers at the Johns Hopkins Kimmel Cancer Center that combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning may allow earlier detection of lung and other cancers.
A multi-institution study found that deletions of a certain tumor-suppressor gene in diffuse gliomas—the most common primary brain tumors—display distinct patterns, signify a poor prognosis in patients, and should be included in models predicting the clinical behavior of these tumors.
